These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 23542170)
1. P63 regulates tubular formation via epithelial-to-mesenchymal transition. Zhang Y; Yan W; Chen X Oncogene; 2014 Mar; 33(12):1548-57. PubMed ID: 23542170 [TBL] [Abstract][Full Text] [Related]
2. P73 tumor suppressor and its targets, p21 and PUMA, are required for madin-darby canine kidney cell morphogenesis by maintaining an appropriate level of epithelial to mesenchymal transition. Zhang Y; Young A; Zhang J; Chen X Oncotarget; 2015 Jun; 6(16):13994-4004. PubMed ID: 26101856 [TBL] [Abstract][Full Text] [Related]
3. Mutant p53 cooperates with knockdown of endogenous wild-type p53 to disrupt tubulogenesis in Madin-Darby canine kidney cells. Zhang Y; Yan W; Chen X PLoS One; 2013; 8(12):e85624. PubMed ID: 24386484 [TBL] [Abstract][Full Text] [Related]
4. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival. Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502 [TBL] [Abstract][Full Text] [Related]
6. A global analysis of the complex landscape of isoforms and regulatory networks of p63 in human cells and tissues. Sethi I; Romano RA; Gluck C; Smalley K; Vojtesek B; Buck MJ; Sinha S BMC Genomics; 2015 Aug; 16():584. PubMed ID: 26251276 [TBL] [Abstract][Full Text] [Related]
7. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma. Cam M; Gardner HL; Roberts RD; Fenger JM; Guttridge DC; London CA; Cam H Oncotarget; 2016 Jul; 7(30):48533-48546. PubMed ID: 27391430 [TBL] [Abstract][Full Text] [Related]
8. TAp63 and DeltaNp63 in cancer and epidermal development. Candi E; Dinsdale D; Rufini A; Salomoni P; Knight RA; Mueller M; Krammer PH; Melino G Cell Cycle; 2007 Feb; 6(3):274-85. PubMed ID: 17264681 [TBL] [Abstract][Full Text] [Related]
9. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas. Chen YK; Hsue SS; Lin LM Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414 [TBL] [Abstract][Full Text] [Related]
10. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Tucci P; Agostini M; Grespi F; Markert EK; Terrinoni A; Vousden KH; Muller PA; Dötsch V; Kehrloesser S; Sayan BS; Giaccone G; Lowe SW; Takahashi N; Vandenabeele P; Knight RA; Levine AJ; Melino G Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15312-7. PubMed ID: 22949650 [TBL] [Abstract][Full Text] [Related]
11. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis. Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901 [TBL] [Abstract][Full Text] [Related]
12. Frequent alteration of p63 expression in human primary bladder carcinomas. Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040 [TBL] [Abstract][Full Text] [Related]
13. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63. Helton ES; Zhu J; Chen X J Biol Chem; 2006 Feb; 281(5):2533-42. PubMed ID: 16319057 [TBL] [Abstract][Full Text] [Related]
14. Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors. Vakonaki E; Soulitzis N; Sifakis S; Papadogianni D; Koutroulakis D; Spandidos DA J Cancer Res Clin Oncol; 2012 Aug; 138(8):1271-8. PubMed ID: 22441934 [TBL] [Abstract][Full Text] [Related]
15. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Truong AB; Kretz M; Ridky TW; Kimmel R; Khavari PA Genes Dev; 2006 Nov; 20(22):3185-97. PubMed ID: 17114587 [TBL] [Abstract][Full Text] [Related]
16. p63: a crucial player in epithelial stemness regulation. Li Y; Giovannini S; Wang T; Fang J; Li P; Shao C; Wang Y; ; Shi Y; Candi E; Melino G; Bernassola F Oncogene; 2023 Nov; 42(46):3371-3384. PubMed ID: 37848625 [TBL] [Abstract][Full Text] [Related]
17. A double dealing tale of p63: an oncogene or a tumor suppressor. Chen Y; Peng Y; Fan S; Li Y; Xiao ZX; Li C Cell Mol Life Sci; 2018 Mar; 75(6):965-973. PubMed ID: 28975366 [TBL] [Abstract][Full Text] [Related]
18. Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation. Wu HH; Wang B; Armstrong SR; Abuetabh Y; Leng S; Roa WHY; Atfi A; Marchese A; Wilson B; Sergi C; Flores ER; Eisenstat DD; Leng RP Nucleic Acids Res; 2021 Mar; 49(5):2740-2758. PubMed ID: 33619536 [TBL] [Abstract][Full Text] [Related]
19. ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma. Katoh I; Tsukinoki K; Hata RI; Kurata SI Neoplasia; 2023 Nov; 45():100938. PubMed ID: 37778252 [TBL] [Abstract][Full Text] [Related]
20. Regulation of claudin-4 via p63 in human epithelial cells. Kojima T; Kohno T; Kubo T; Kaneko Y; Kakuki T; Kakiuchi A; Kurose M; Takano KI; Ogasawara N; Obata K; Nomura K; Miyata R; Konno T; Ichimiya S; Himi T Ann N Y Acad Sci; 2017 Oct; 1405(1):25-31. PubMed ID: 28856683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]